About us
Company
Strategy & Mission
Management
Our Technology
Marinosolv
Data
Benefits
Services & BD
Partnerships
Services
News
Solv4U News
Publications
Contact
Marinomed
Scientific Publications
Scientific Publications
Whitepapers
ALL
2024
2020
2019
2010
Immunology Marinomed
Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution
Sladek, S. et al., Clin Ophthalmol. 2024;18:2797-2811; doi: https://doi.org/10.2147/OPTH.S476163
(3 MB)
Immunology Marinomed
Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
Zieglmayer et al., Clin Exp Allergy. 2020; 00:1–13.
(1 MB)
Immunology Marinomed
Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide
Nakowitsch et al., Pharmaceutics 2020, 12(9), 847
(1 MB)
Immunology Marinomed
Topical Pergolide Enhance Corneal Nerve Regrowth Following Induced Corneal Abrasion
Zhang et al., Invest Ophthalmol Vis Sci. 2020; 61(1):4.
(2 MB)
Immunology Marinomed
Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation
Siegl et al., European Journal of Pharmaceutics and Biopharmaceutics 134, 2019, 88-95
(5 MB)
Immunology Marinomed
Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation
Lindner, I. et. al.BMC Immunol. 2010 May 21;11:24. doi: 10.1186/1471-2172-11-24
(2 MB)
Marinomed Whitepapers
Whitepaper July 2024
Marinosolv®-Enabled Estradiol as Novel Treatment for Menopausal and Postmenopausal Symptoms
Whitepaper March 2024
Marinosolv® - A Novel Approach to Increase the Solubility and Improve the Bioavailability of Promising Low-Soluble Drugs